Adderall Xr
Abstract
2Several central nervous system agents are Food and Drug Administration (FDA)-approved for the treatment of ADHD, including the cerebral stimulants (amphetamines and methylphenidate derivatives), atomoxetine (Strattera ® ), clonidine extendedrelease (Kapvay ® ) and guanfacine extended-release (Intuniv
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
2Several central nervous system agents are Food and Drug Administration (FDA)-approved for the treatment of ADHD, including the cerebral stimulants (amphetamines and methylphenidate derivatives), atomoxetine (Strattera ® ), clonidine extendedrelease (Kapvay ® ) and guanfacine extended-release (Intuniv
Key concepts: Atomoxetine, Methylphenidate, Guanfacine, Clonidine, Attention deficit hyperactivity disorder, Drug class, Dextroamphetamine, Medicine